Gammaglobulins, autoantibodies, therapeutic antibodies and anti-drug antibodies in rheumatoid arthritis

被引：0
作者：
Gottenberg, J. -E. [1 ]
机构：
[1] Univ Hosp Strasbourg, Natl Ctr Syst Autoimmune Dis, Strasbourg, France
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2014年 / 178卷
关键词：
CITRULLINATED PROTEINS; DOUBLE-BLIND; TRIAL; METHOTREXATE; ASSOCIATION; MULTICENTER; COMBINATION; ADALIMUMAB; RECEPTOR; REGISTRY;
D O I：
10.1111/cei.12534
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 117
页数：3
相关论文
共 50 条
[41]   Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis [J].
Suwannalai, Parawee ;
Trouw, Leendert A. ;
Toes, Rene E. M. ;
Huizinga, Tom W. J. .
MODERN RHEUMATOLOGY, 2012, 22 (01) :15-20
[42]   Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies [J].
Opris, Daniela ;
Mazilu, Diana ;
Ionescu, Ruxandra .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) :S40-S41
[43]   Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis [J].
Farid, Sima Sh. ;
Azizi, Gholamreza ;
Mirshafiey, Abbas .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (04) :379-386
[44]   Anti-citrullinated peptide antibodies profiling in established rheumatoid arthritis [J].
Manca, Maria Laura ;
Alunno, Alessia ;
D'Amato, Claudia ;
Bistoni, Onelia ;
Puxeddu, Ilaria ;
Gerli, Roberto ;
Migliorini, Paola ;
Pratesi, Federico .
JOINT BONE SPINE, 2018, 85 (04) :441-445
[45]   Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab [J].
Gorovits, B. ;
Baltrukonis, D. J. ;
Bhattacharya, I ;
Birchler, M. A. ;
Finco, D. ;
Sikkema, D. ;
Vincent, M. S. ;
Lula, S. ;
Marshall, L. ;
Hickling, T. P. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03) :348-365
[46]   Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA [J].
Ogric, Manca ;
Zigon, Polona ;
Lakota, Katja ;
Praprotnik, Sonja ;
Drobne, David ;
Stabuc, Borut ;
Sodin-Semrl, Snezna ;
Cucnik, Sasa .
CLINICAL RHEUMATOLOGY, 2019, 38 (02) :361-370
[47]   Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies [J].
Bar-Yoseph, Haggai ;
Pressman, Sigal ;
Blatt, Alexandra ;
Vainberg, Shiran Gerassy ;
Maimon, Naama ;
Starosvetsky, Elina ;
Ungar, Bella ;
Ben-Horin, Shomron ;
Shen-Orr, Shai S. ;
Chowers, Yehuda .
GASTROENTEROLOGY, 2019, 157 (05) :1338-+
[48]   The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease [J].
Fousekis, Fotios S. ;
Papamichael, Konstantinos ;
Kourtis, Georgios ;
Albani, Eleni N. ;
Orfanidou, Afroditi ;
Saridi, Maria ;
Katsanos, Konstantinos H. ;
Christodoulou, Dimitrios K. .
ANNALS OF GASTROENTEROLOGY, 2022, 35 (01) :1-7
[49]   Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients [J].
Chen, Po-Ku ;
Chen, Yi-Ming ;
Chen, Jeremy J. W. ;
Chen, Der-Yuan .
RHEUMATOLOGY, 2025, 64 (05) :2451-2460
[50]   Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study [J].
Eng, Grith Petersen ;
Bouchelouche, Pierre ;
Bartels, Else Marie ;
Bliddal, Henning ;
Bendtzen, Klaus ;
Stoltenberg, Michael .
PLOS ONE, 2016, 11 (09)
12345